US 12281164
Genetically engineered dual-targeting chimeric antigen receptor and use thereof
granted A61KA61K2039/507A61P
Quick answer
US patent 12281164 (Genetically engineered dual-targeting chimeric antigen receptor and use thereof) held by WEST CHINA HOSPITAL, SICHUAN UNIVERSITY expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- WEST CHINA HOSPITAL, SICHUAN UNIVERSITY
- Grant date
- Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/507, A61P, A61P35/04